MedPath
NMPA Approval

Ustekinumab Injection

国药准字S20240050

October 29, 2024

Drug Information

乌司奴单抗注射液

赛乐信

注射剂

预充式注射器:45mg(0.5ml)/支

生物制品

October 29, 2024

Company Information

Applicant Company

杭州市莫干山路866号祥符桥

Manufacturing Company

泰州市药城大道907号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

乌司奴单抗注射液 - NMPA 批准文号 | MedPath